Ishida Hideyuki*1,2, Chikatani Kenichi*1, Mori Yoshiko*1,2, Momose Syuji*3, Osada Hisato*4, Yamano Tomoki*5, Tomita Naohiro*5, Akiyama Yasuki*6, Hirata Keiji*6, Nuguruma Naoki*7, Takayama Tetsuji*7, Nishida Yoshihiro*8, Ishikawa Hideki*9
*1Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, *2Department of Clinical Genomics, Saitama Medical Center, Saitama Medical University, *3Department of Pathology, Saitama Medical Center, Saitama Medical University, *4Department of Radiology, Saitama Medical Center, Saitama Medical University, *5Division of Lower GI Surgery, Department of Surgery, Hyogo College of Medicine, *6Department of Surgery 1, School of Medicine, University of Occupational and Environmental Health, *7Department of Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Sciences, *8Department of Rehabilitation, Nagoya University Hospital, *9Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine
Journal of Hereditary Tumors 20(2): 45-58, 2020.